TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
SKYE

Skye Bioscience, Inc.

Healthcare · Biotechnology

1.60$ -7.6% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Skye Bioscience, Inc. (SKYE)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 62.6% of the shares are freely tradable; institutional investors hold 46.0%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 46.0%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.2%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 62.6%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 4.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 4Mio.

Largest Shareholders

Institutions

Institutions SKYE
Name Stake (%) Shares Change (%) Date
5AM Venture Management, LLC 27.33 9,681,763 +0.0 06/30/2026
Versant Venture Management LLC 5.67 2,007,704 +0.0 06/30/2026
Baker Bros Advisors LP 4.45 1,575,243 +8.6 03/31/2026
Vanguard Capital Management, LLC 2.16 764,457 +0.0 03/31/2026
Sphera Funds Management Ltd. 1.92 678,928 +41.8 03/31/2026
BlackRock Inc 0.81 286,131 +1.5 03/31/2026
Geode Capital Management, LLC 0.78 277,256 +31.9 03/31/2026
Junked Platinum Investment Management Ltd 0.66 233,095 +0.0 03/31/2026
Millennium Management LLC 0.56 198,524 -23.1 06/30/2026

Funds

Funds SKYE
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 1.59 561,832 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings SKYE
Person Role Shares Value As of Type
Schwab Andrew J. Director 1,163,240 1,861,185 $ Aug 20, 2026 indirect
5AM Partners VII, LLC 10% Owner 1,163,240 1,861,185 $ Aug 20, 2026 indirect
Dhillon Punit Chief Executive Officer 177,478 283,965 $ Aug 7, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 20, 2026 Schwab Andrew J. Director Sell 6,495 0.32 2,078
Aug 20, 2026 Schwab Andrew J. Director Sell 46 0.32 15
Aug 20, 2026 Schwab Andrew J. Director Sell 1,159 0.32 371
Aug 20, 2026 5AM Partners VII, LLC 10% Owner Sell 6,495 0.32 2,078
Aug 20, 2026 5AM Partners VII, LLC 10% Owner Sell 46 0.32 15
Aug 20, 2026 5AM Partners VII, LLC 10% Owner Sell 1,159 0.32 371
Aug 19, 2026 Schwab Andrew J. Director Sell 57,476 0.35 20,117
Aug 19, 2026 Schwab Andrew J. Director Sell 409 0.35 143
Aug 19, 2026 Schwab Andrew J. Director Sell 10,255 0.35 3,589
Aug 19, 2026 5AM Partners VII, LLC 10% Owner Sell 57,476 0.35 20,117
Aug 19, 2026 5AM Partners VII, LLC 10% Owner Sell 409 0.35 143
Aug 19, 2026 5AM Partners VII, LLC 10% Owner Sell 10,255 0.35 3,589
Aug 18, 2026 Schwab Andrew J. Director Sell 253,080 0.38 96,170
Aug 18, 2026 Schwab Andrew J. Director Sell 1,830 0.38 695
Aug 18, 2026 Schwab Andrew J. Director Sell 45,090 0.38 17,134
Aug 18, 2026 5AM Partners VII, LLC 10% Owner Sell 253,080 0.38 96,170
Aug 18, 2026 5AM Partners VII, LLC 10% Owner Sell 1,830 0.38 695
Aug 18, 2026 5AM Partners VII, LLC 10% Owner Sell 45,090 0.38 17,134
Aug 7, 2026 Dhillon Punit Chief Executive Officer Other 1,090,000 0.00

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?